Table 1.

Biodistribution of N-(2-diethylaminoethyl) 4-[¹⁸F]fluorobenzamide ([¹⁸F]-DAFBA) in normal Balb/c ICR mice at various time points after injection (mean±SEM; n=5)

	Percent Injected Dose per gram Tissue (%ID/g)
ORGAN	30 Min	60 Min	120 Min	180 Min
Liver	3.12 ± 0.62	3.61 ± 0.48	1.14 ± 0.41	1.12 ± 0.20
Spleen	2.35 ± 0.07	1.87 ± 0.46	0.43 ± 0.25	0.53 ± 0.08
Lung	1.75 ± 0.43	1.84 ± 0.41	0.42 ± 0.14	0.49 ± 0.07
Heart	1.10 ± 0.14	0.92 ± 0.10	0.28 ± 0.05	0.23 ± 0.03
Kidneys	4.13 ± 0.68	4.20 ± 0.41	1.58 ± 0.51	1.34 ± 0.36
Intestine	0.91 ± 0.32	1.39 ± 0.54	0.26 ± 0.26	0.40 ± 0.11
Muscle	0.88 ± 0.13	0.65 ± 0.11	0.18 ± 0.10	0.16 ± 0.03
Bone	0.81 ± 0.19	0.69 ± 0.08	0.20 ± 0.06	0.24 ± 0.10
Blood	0.78 ± 0.07	0.67 ± 0.05	0.20 ± 0.04	0.21 ± 0.03
Brain	2.16 ± 0.32	1.54 ± 0.24	0.52 ± 0.07	0.46 ± 0.07